Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)

O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), L. Servais (Liege, Belgium), C. Straathof (Leiden, Netherlands), U. Schara (Essen, Germany), T. Voit (London, United Kingdom), E. Mercuri (Rome, Italy), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium)

Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session: Rare and ultra-rare diseases and the lungs: updates and new perspectives
Session type: Oral Presentation
Number: 5330
Disease area: -

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), L. Servais (Liege, Belgium), C. Straathof (Leiden, Netherlands), U. Schara (Essen, Germany), T. Voit (London, United Kingdom), E. Mercuri (Rome, Italy), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium). Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD). 5330

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017



Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD)
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018

Efficacy of Idebenone in respiratory decline in Duchenne muscular dystrophy (DMD): Comparison of analysis methods
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017



Observation cohort study of cause of death in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012


Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017

The impact of treatment with steroids on lung function of children with Duchenne muscular dystrophy: experience from a single centre
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020


Effect on survival of long-term non-invasive ventilation and cardiac management for Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: Suppl. 50, 184s
Year: 2006

Introduction of domiciliary mechanical insufflation-exsufflation can reduce the incidence of crisis admissions in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012


Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference?
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001

Which are the most informative parameters to follow the respiratory decline in Duchenne muscular dystrophy?
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Gastrointestinal dysfunction in ventilated patients with Duchenne muscular dystrophy
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012

The change of ventilation function in the patients of Duchenne muscular dystrophy under and beyond 12 years old and the effects of rehabilitation
Source: Eur Respir J 2007; 30: Suppl. 51, 766s
Year: 2007

Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood
Source: Eur Respir J, 51 (2) 1701418; 10.1183/13993003.01418-2017
Year: 2018



Ventilatory assistance in patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: 468-469
Year: 2006


Effect of steroid therapy on lung volumes in duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2004; 24: Suppl. 48, 521s
Year: 2004

Inefficient cough in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012

Nutritional status and admission risk in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013


Respiratory kinematics in Duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2007; 30: Suppl. 51, 376s
Year: 2007

Implication of regular pulmonary function evaluation in Duchenne muscular dystrophy
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Respiratory muscle testing: a valuable tool for young patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: Suppl. 50, 357s
Year: 2006